MedTrace Logo

Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis

NCT03411876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-04-16

No results posted yet for this study

Summary

Aim of this study is to investigate the effects of an Oxymizer pendant nasal cannula in hypoxemic patients with idiopathic pulmonary fibrosis during walking.

Conditions

Interventions

DEVICE

Oxymizer® pendant nasal cannula

Supplemental oxygen is provided by an Oxymizer pendant nasal cannula.

DEVICE

conventional nasal cannula

Supplemental oxygen is provided by a conventional nasal cannula.

Sponsors & Collaborators

  • Schön Klinik Berchtesgadener Land

    collaborator OTHER

  • Klaus Kenn

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2019-01-15
Completion
2019-01-15
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03411876 on ClinicalTrials.gov